Frequency of and risk factors for depression among participants in the swiss HIV Cohort Study (SHCS)

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Anagnostopoulos, Alexia ^a   Ledergerber, Bruno ^a   Jaccard, René ^b   Shaw, Susy Ann ^c   Stoeckle, Marcel ^d   Bernasconi, Enos ^e   Barth, Jörgen ^f   Calmy, Alexandra ^g   Berney, Alexandre ^h   Jenewein, Josef ^a   Weber, Rainer ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Independent Researcher   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^f UNIVERSITY OF BERN   (Switzerland)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^h LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HIGH RISK PATIENT; HOMOSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MORTALITY; PHYSICAL ACTIVITY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; SUICIDE; SWITZERLAND; VIRUS LOAD; VIRUS TRANSMISSION; PSYCHOLOGY; REGRESSION ANALYSIS; STATISTICAL MODEL; SWEDEN;

DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SWEDEN;

EID: 84949431867     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140943     Document Type: Article

References (34)

1. Dew MA, Becker JT, Sanchez J, Caldararo R, Lopez OL, Wess J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: A longitudinal evaluation. Psychological medicine. 1997; 27(2):395-409.
2. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of general psychiatry. 2001; 58(8):721-8.7
3. Ciesla JA, Roberts JE. Meta-Analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiat. 2001; 158(5):725-30.3
4. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, et al. The functioning and wellbeing of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989; 262(7):914-9.
5. Glassman AH. Depression and cardiovascular comorbidity. Dialogues Clin Neurosci. 2007; 9(1):9-17.2
6. Boarts JM, Sledjeski EM, Bogart LM, Delahanty DL. The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS and behavior. 2006; 10 (3):253-61.5
7. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS (London, England). 1999; 13(13):1763-9.
8. Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: A metaanalysis. Annals of behavioral medicine: A publication of the Society of Behavioral Medicine. 2014; 47 (3):259-69.
9. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biological psychiatry. 2003; 54(3):295-306.5
10. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. American journal of public health. 2004; 94(7):1133-40.3
11. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women-Longitudinal analysis from the HIV epidemiology research study. Jama-J Am Med Assoc. 2001; 285(11):1466-74.
12. Golub ET, Astemborski JA, Hoover DR, Anthony JC, Vlahov D, Strathdee SA. Psychological distress and progression to AIDS in a cohort of injection drug users. Journal of acquired immune deficiency syndromes (1999). 2003; 32(4):429-34.
13. Keiser O, Spoerri A, Brinkhof MW, Hasse B, Gayet-Ageron A, Tissot F, et al. Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008. The American journal of psychiatry. 2010; 167(2):143-50. doi: 10.1176/appi.ajp.2009.090506512
14. Del Guerra FB, Fonseca JL, Figueiredo VM, Ziff EB, Konkiewitz EC. Human immunodeficiency virusassociated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways. Journal of neurovirology. 2013; 19(4):314-27. doi: 10.1007/s13365-013-0177-73
15. Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: A systematic review and meta-Analysis of longitudinal studies. Journal of affective disorders. 2013; 150(3):736-44. doi: 10.1016/j.jad.2013.06. 0045
16. Aljassem K, Raboud JM, Hart TA, Benoit A, Su D, Margolese SL, et al. Gender Differences in Severity and Correlates of Depression Symptoms in People Living with HIV in Ontario, Canada. Journal of the International Association of Providers of AIDS Care. 2014.
17. Taniguchi T, Shacham E, Onen NF, Grubb JR, Overton ET. Depression severity is associated with increased risk behaviors and decreased CD4 cell counts. AIDS care. 2014; 26(8):1004-12. doi: 10. 1080/09540121.2014.8803993
18. Schumacher JE, McCullumsmith C, Mugavero MJ, Ingle-Pang PE, Raper JL, Willig JH, et al. Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment. AIDS and behavior. 2013; 17(8):2781-91. doi: 10.1007/s10461-012-0342-77
19. Swiss HIVCS, Schoeni-Affolter F, Ledergerber B, Rickenbach M, Rudin C, Gunthard HF, et al. Cohort profile: The Swiss HIV Cohort study. Int J Epidemiol. 2010; 39(5):1179-89. doi: 10.1093/ije/dyp3210
20. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. Journal of general internal medicine. 1997; 12(7):439-45.
21. Kacanek D, Jacobson DL, Spiegelman D, Wanke C, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: A longitudinal analysis from the Nutrition for Healthy Living study. Journal of acquired immune deficiency syndromes (1999). 2010; 53(2):266-72.
22. Piccinelli M, Wilkinson G. Gender differences in depression. Critical review. The British journal of psychiatry: The journal of mental science. 2000; 177:486-92.
23. Goodwin RD. Association between physical activity and mental disorders among adults in the United States. Preventive medicine. 2003; 36(6):698-703.3
24. McManus H, Petoumenos K, Franic T, Kelly MD, Watson J, O'Connor CC, et al. Determinants of suicide and accidental or violent death in the Australian HIV Observational Database. PloS one. 2014; 9(2): e89089. doi: 10.1371/journal.pone.00890899
25. Caldwell JZ, Gongvatana A, Navia BA, Sweet LH, Tashima K, Ding M, et al. Neural dysregulation during a working memory task in human immunodeficiency virus-seropositive and hepatitis C coinfected individuals. Journal of neurovirology. 2014; 20(4):398-411. doi: 10.1007/s13365-014-0257-30
26. Franke L, Therstappen E, Schlosser B, Biermer M, Berg T, Schafer M, et al. A Preliminary Study on the Relationship between Platelet Serotonin Transporter Functionality, Depression, and Fatigue in Patients with Untreated Chronic Hepatitis C. Depression research and treatment. 2014; 2014:821381. doi: 10. 1155/2014/8213819
27. Sheridan DA, Bridge SH, Crossey MM, Felmlee DJ, Thomas HC, Neely RD, et al. Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency. Metabolic brain disease. 2014.
28. Kelly JA, Murphy DA, Bahr GR, Brasfield TL, Davis DR, Hauth AC, et al. AIDS/HIV risk behavior among the chronic mentally ill. The American journal of psychiatry. 1992; 149(7):886-9.
29. Kelly JA, Murphy DA, Bahr GR, Koob JJ, Morgan MG, Kalichman SC, et al. Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with human immunodeficiency virus (HIV) infection. Health psychology: official journal of the Division of Health Psychology, American Psychological Association. 1993; 12(3):215-9.
30. Weber R, Huber M, Rickenbach M, Furrer H, Elzi L, Hirschel B, et al. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: The Swiss HIV Cohort Study. HIV medicine. 2009; 10(7):407-16. doi: 10.1111/j.1468-1293.2009.00701.x4
31. Weber R, Huber M, Battegay M, Staehelin C, Castro Batanjer E, Calmy A, et al. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study. HIV medicine. 2014;(in print).
32. Gutierrez F, Garcia L, Padilla S, Alvarez D, Moreno S, Navarro G, et al. Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs. HIV medicine. 2014; 15(4):213-23. doi: 10.1111/hiv.121046
33. Journot V, Chene G, De Castro N, Rancinan C, Cassuto JP, Allard C, et al. Use of efavirenz is not associated with a higher risk of depressive disorders: A substudy of the randomized clinical trial ALIZEANRS 099. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America. 2006; 42(12):1790-9.
34. Barth J, Munder T, Gerger H, Nuesch E, Trelle S, Znoj H, et al. Comparative efficacy of seven psychotherapeutic interventions for patients with depression: A network meta-Analysis. PLoS medicine. 2013; 10(5):e1001454. doi: 10.1371/journal.pmed.10014542